JHS Svendgaard Laboratories' Q3 FY 2025-26 Quarterly Results
- 11 Feb 2026
Result Summary
- JHS Svendgaard Laboratories Ltd reported a 1.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 4.0%.
- Its expenses for the quarter were up by 1.5% QoQ and down 3.0% YoY.
- The net profit decreased 495.0% QoQ and decreased 142.9% YoY.
- The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd stood at 0.09 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 23.85 | 23.42 | 22.93 | 1.8% | 4.0% |
Total Expenses | 23.77 | 23.43 | 24.51 | 1.5% | -3.0% |
Profit Before Tax | 0.08 | -0.02 | -1.58 | -500.0% | -105.1% |
Tax | -0.71 | 0.18 | 0.25 | -494.4% | -384.0% |
Profit After Tax | 0.79 | -0.20 | -1.84 | -495.0% | -142.9% |
Earnings Per Share | 0.09 | 0.00 | -0.21 | - | -142.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
JHS Svendgaard Laboratories Ltd is a company involved in the manufacturing and distribution of oral care products. The company operates primarily in the consumer goods industry, focusing on products such as toothbrushes, toothpastes, and other dental care items. It caters to both domestic and international markets, enhancing its reach within the oral hygiene segment. Recent developments for the company might include expansion in product lines or geographical reach, though specific recent events are not detailed in the provided context.
Revenue
During Q3FY26, JHS Svendgaard Laboratories Ltd reported a total income of ₹23.85 crores. This reflects a quarter-over-quarter (QoQ) increase of 1.8% from ₹23.42 crores in Q2FY26. Year-over-year (YoY), the total income increased by 4.0% from ₹22.93 crores in Q3FY25. These figures indicate a consistent growth in revenue over the past quarters and years, demonstrating the company's ability to enhance its income over time.
Profitability
In terms of profitability, JHS Svendgaard Laboratories Ltd showed a notable improvement. The Profit Before Tax for Q3FY26 stood at ₹0.08 crores, which is a substantial recovery from a loss of ₹0.02 crores in Q2FY26 and a loss of ₹1.58 crores in Q3FY25. The company also reported a Profit After Tax of ₹0.79 crores in Q3FY26, contrasting with a loss of ₹0.20 crores in Q2FY26 and a loss of ₹1.84 crores in Q3FY25. Earnings Per Share for Q3FY26 were ₹0.09, up from ₹0.00 in the previous quarter and from negative values in the corresponding period last year.
Operating Metrics
Total expenses for Q3FY26 were ₹23.77 crores, marking a QoQ increase of 1.5% from ₹23.43 crores in Q2FY26, but a decline of 3.0% YoY from ₹24.51 crores in Q3FY25. This indicates the company's efforts in managing and possibly reducing its cost base compared to the previous year. The tax component for Q3FY26 was -₹0.71 crores, representing a significant reduction from ₹0.18 crores in Q2FY26 and ₹0.25 crores in Q3FY25. This negative tax value suggests a reversal or credit situation during the quarter. These figures reflect the company's operational adjustments and their impact on financial performance.